ALNYLAM PHARMACEUTICALS, INC. G&A Expense 2008-2018 | ALNY
Beta
What is g&a expense?
General and administrative expenses cover corporate overhead costs including management salaries, office expenses, and administrative costs.
What is ALNYLAM PHARMACEUTICALS, INC.'s current g&a expense?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual g&a expense for 2017 was $199.4M, a 123.12% increase from 2016. ALNYLAM PHARMACEUTICALS, INC. g&a expense for the quarter ending June 30, 2018 was $84.7M.
What was ALNYLAM PHARMACEUTICALS, INC.'s g&a expense in 2016?
ALNYLAM PHARMACEUTICALS, INC. annual g&a expense for 2016 was $89.4M, a 47.42% increase from 2015.
What was ALNYLAM PHARMACEUTICALS, INC.'s g&a expense in 2015?
ALNYLAM PHARMACEUTICALS, INC. annual g&a expense for 2015 was $60.6M, a 36.12% increase from 2014.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year g&a expense CAGR?
ALNYLAM PHARMACEUTICALS, INC. g&a expense grew at a compound annual growth rate (CAGR) of 34.91% from FY2012 to FY2017, going from $44.6M to $199.4M over 5 years.
G&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+34.9%
FY2012
$44.6M
→
FY2017
$199.4M
08091011121314151617
5 years selected
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →